Kazia Therapeutics (KZIA) Current Deferred Revenue (2016 - 2018)
Kazia Therapeutics' (KZIA) quarterly Current Deferred Revenue came in at $104471.1 in Q2 2018, up 239.2% YoY from $30799.6 in Q2 2017, and up 239.2% on a QoQ basis from $30799.6 in Q2 2017.
Kazia Therapeutics (KZIA) Current Deferred Revenue (2016 - 2018) Analysis & Trends
Kazia Therapeutics (KZIA) has 3 years of Current Deferred Revenue data on file, last reported at $104471.1 in Q2 2018.
- Quarterly Current Deferred Revenue rose 239.2% year-over-year to $104471.1 in Q2 2018, while the trailing twelve-month figure through Jun 2018 was $104471.1 (up 239.2% YoY) and the FY2018 annual result came in at $104471.1, up 237.91% from the prior year.
- Current Deferred Revenue grew to $104471.1 in Q2 2018, from $30799.6 in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $137892.6 in Q4 2016 to a low of $30617.0 in Q2 2016.
- A 3-year average of $75945.1 and a median of $67635.4 in 2017 frame the typical range for Current Deferred Revenue.
- Annual changes were most pronounced in 2017 — Current Deferred Revenue grew 0.6% — and 2018, when it soared 239.2%.
- Tracing KZIA's Current Deferred Revenue over 3 years: stood at $137892.6 in 2016, then plunged by 77.66% to $30799.6 in 2017, then soared by 239.2% to $104471.1 in 2018.
- The last three Current Deferred Revenue figures came in at $104471.1 (Q2 2018), $30799.6 (Q2 2017), and $137892.6 (Q4 2016), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Kazia Therapeutics | 4.22 Bn | 4.22 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2018 | 104,471.09 |
| Jun 30, 2017 | 30,799.62 |
| Dec 31, 2016 | 137,892.62 |
| Jun 30, 2016 | 30,617.04 |